Elago, Margaux Candice .
HRN: 15-76-82 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/04/2024
CEFUROXIME 250MG/5ML, 50ML SUSPENSION (BOT)
02/04/2024
02/10/2024
PO
6.5ml
BID
URTI
Checking Final Appropriateness
Indication: Empiric Type of Infection: URTI Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes